Reading Your Practice P&L: Benchmarks by Specialty

Every practice P&L looks the same at first glance: revenue on top, expenses below, net income at the bottom. What separates a healthy practice from one drifting into trouble is not the format of the P&L; it is the ratios inside it. A 60% overhead ratio looks alarming in a dermatology practice and looks normal in a primary care office. Reading a medical P&L means reading it against the right specialty benchmark, not against a generic small-business standard.

For a physician-owner in Idaho Falls, Twin Falls, or Provo, learning to read the P&L quickly each month is one of the highest-leverage skills there is. This piece covers the six ratios that matter most, how they differ by specialty, why trend beats snapshot, and the warning signs worth acting on before the year closes.

The Six Ratios That Matter Most on a Practice P&L

Six ratios do most of the work of reading a medical P&L:

  • Provider compensation as a percentage of net collections
  • Non-provider staff payroll as a percentage of net collections
  • Occupancy (rent, utilities, common area) as a percentage of net collections
  • Medical supplies as a percentage of net collections
  • Total overhead (everything except provider comp) as a percentage of net collections
  • Net operating income before physician distributions as a percentage of net collections

Every specialty has a range for each. The point is not to hit an exact number; it is to know when a ratio has drifted materially outside its normal range for the specialty and to understand why before the drift becomes structural.

How Overhead Differs by Specialty

Overhead percentage is the single most misread number on a medical P&L. General surgery and orthopedics typically run lower overhead because their per-visit revenue is high. Primary care and pediatrics run higher overhead because their per-visit revenue is lower and staff-intensive workflows are the same either way.

Dermatology and dentistry sit differently again, with higher supplies and equipment ratios but often lower staff ratios. Comparing a primary care practice’s overhead percentage to a dermatology benchmark is not useful; comparing it to peer primary care practices is.

Provider Compensation as a Percentage of Revenue

Provider comp is a management ratio, not a cost ratio. What matters is not whether the number is high, but whether the practice is producing the revenue to support it. A provider comp percentage rising while collections are flat is one of the earliest signs that the compensation model has drifted out of alignment with production.

In a physician-owner practice, this number includes the owner’s own take. Reading it monthly forces a conversation about what the practice is actually leaving to reinvest, and whether the current pace of distributions is sustainable through a slow quarter.

Reading Trend, Not Snapshot

A single month’s P&L is noise. Vacations, seasonal patient patterns, and payer timing all move the numbers around. Trend is signal.

The most useful view is a rolling three-month average of each key ratio, laid alongside the same period twelve months prior. A ratio moving 1 to 2 percentage points month over month is normal. A ratio moving 3 to 5 percentage points over a rolling three-month window is a real change and worth an owner conversation.

Practices that read the P&L this way catch drift while there is time to respond. Practices that only look at the annual number see the drift after it has already compounded.

The Warning Signs to Act on This Quarter

Four patterns show up on a P&L before they show up in cash:

Staff payroll rising as a percentage of collections without a corresponding rise in patient volume usually means either wage inflation the practice absorbed without adjusting prices or fee schedules, or an FTE creep that snuck up over a few hires.

Medical supplies rising faster than revenue often means either genuine cost inflation from vendors or a workflow change that shifted the mix toward higher-supply procedures. Both deserve a look.

Occupancy rising as a percentage of revenue is almost always a revenue problem, not a rent problem. Rent is fixed; the ratio moves because the numerator moved.

Net operating income compression without a specific line item cause usually means a slow drift across three or four accounts, none large enough to notice individually. That is the version worth the closest look, because the fix is workflow rather than a single vendor renegotiation.

Cooper Norman’s healthcare accounting team builds monthly practice P&L reviews for physician-owned groups across Idaho and Utah, with specialty-appropriate benchmarks and trend analysis. To have your own P&L read against the right benchmarks, talk with a Cooper Norman advisor.

Retail Shrinkage: How to Measure, Reduce, and Account For It

A small Idaho grocer runs at a reported gross margin of 28 percent. The physical inventory count at year-end reveals a 2.1 percent shrink rate against sales. That $180,000 in missing inventory (against $8.5 million in annual revenue) turns a healthy margin into a mediocre one and quietly consumes half the store’s operating profit.

Shrinkage happens in every retail operation. Some of it is unavoidable. Most of it is measurable, reducible, and eventually preventable to a large degree. What separates well-run retailers from struggling ones is not whether they have shrink; it is whether they can see it, respond to it, and record it correctly.

How Shrinkage Actually Hits the P&L

Shrinkage is the difference between the inventory the books say should be on hand and the inventory the count actually finds. It has multiple root causes: external theft (shoplifting), internal theft (employee theft), vendor fraud, receiving errors, damage, spoilage, ticket switching, and administrative error. Each root cause has a different fix.

The P&L impact runs through cost of goods sold. When the year-end physical count comes in short, the inventory adjustment increases COGS by the shortfall amount, reducing gross margin dollar for dollar. A 1 percent shrink rate on $10 million in revenue is $100,000 pulled directly out of gross profit.

The Shrink-to-Sales KPI and Its Peer Benchmarks

The industry standard shrink metric is inventory shrink as a percentage of retail sales. Peer benchmarks vary by category. Supermarkets and grocery typically run 1.5 to 2.5 percent; general merchandise and mass retail run 1 to 1.5 percent; specialty retail and apparel can run higher, especially in high-theft categories.

A retailer running above the peer benchmark for their category is losing meaningfully more than competitors. A retailer running below is either exceptional at loss prevention, is missing shrink through poor cycle counting, or has categories that structurally do not shrink.

Cycle Counts vs. Full Physical Inventory

The traditional model runs one full physical inventory per year, at fiscal year-end. That approach produces one data point per year and delivers no visibility between counts. Shrinkage that occurred in month three is not discovered until month twelve.

Cycle counting distributes the counting workload across the year. Every SKU gets counted several times annually, higher-risk categories counted more frequently. The result is continuous visibility into shrink by SKU and department, plus fewer surprises at year-end.

The transition from full physical inventory to cycle counting typically requires a good inventory management system and disciplined counting procedures. The return is significant: cycle counting retailers usually see 20 to 30 percent lower shrink rates over time simply because problems get detected and addressed sooner.

Journal Entry Treatment of Shrinkage

Two journal entries capture shrinkage properly. The first, during the year, records estimated shrink each period based on trend or expected rate. This reserve smooths the P&L impact rather than dropping it all at year-end.

Debit COGS (Shrinkage) [estimated period shrink]
Credit Inventory Reserve for Shrinkage [reserve account]

The second, at physical inventory, reconciles the reserve to actual shrink discovered.

Debit COGS or Credit COGS (as needed to reconcile)
Debit or Credit Inventory Reserve
Credit or Debit Inventory (to write down to actual counted value)

Some retailers skip the reserve and take shrink entirely at physical count. That approach is simpler but produces a large gross margin hit at year-end that distorts the P&L.

The Loss Prevention Investments That Actually Pay Back

Four investment categories generally produce positive ROI for retailers running above peer benchmarks:

  • Video surveillance with analytics. Modern systems detect specific behaviors (sweethearting at the register, cart pushouts) rather than requiring constant human monitoring.
  • Exception reporting on POS transactions. Analytics that flag unusual return patterns, discount abuse, or void frequency at the register-operator level.
  • Receiving accuracy tools. Barcode scanning and vendor scorecarding catch vendor fraud and receiving errors before they become inventory adjustments.
  • Employee background checks and integrity testing. Internal theft accounts for roughly a third of retail shrink in most categories. Hiring quality drives it down.

Big-ticket investments (article surveillance tags, uniformed security, exit gates) can help in high-theft environments but generally have less favorable ROI than the process and analytics investments.

External vs. Internal Theft: Different Playbooks

External theft (shoplifting) responds to visibility, layout design, and product placement. Products displayed near cash wraps or in view of staff are less exposed. Certain high-theft categories (razors, small electronics, cosmetics) sometimes justify locked cases or receipt-check exits.

Internal theft (employee theft, sweethearting, register manipulation) is best addressed through hiring practices, segregation of duties, and exception reporting rather than surveillance alone. Employees who know their transactions get reviewed behave differently.

Shrinkage is one of the most persistent silent costs in retail, and it responds to management attention more than most retailers realize. The retail advisory team at Cooper Norman works with Idaho and Utah retailers to benchmark shrink rates, evaluate loss prevention investments, and set up cycle counting that catches problems earlier. Our audit and assurance group reviews inventory controls as part of every retail audit.

Understanding RVU-Based Physician Compensation Models

RVU-based compensation is now the dominant model for employed physicians and a common structure inside physician-owned groups too. It ties pay to production, and on the surface, that sounds like a fair alignment: work more, earn more. Underneath, the model has enough moving parts that a physician can sign a contract that looks good on the top line and produces less take-home than a straightforward salary would.

For physicians in Idaho or Utah looking at a new employment offer or considering how to structure a partner comp arrangement in a small group, understanding what RVUs actually measure and how they convert into pay is essential. This walk-through covers the anatomy of an RVU, how conversion factors work, the tradeoff between base and pure RVU structures, and the scenarios worth modeling before signing.

What an RVU Is (and Why wRVU Is the Number That Pays)

A relative value unit, or RVU, is Medicare’s measure of the resources it takes to deliver a service. Each CPT code has an RVU value published in the Medicare Physician Fee Schedule, and the total RVU for a code is the sum of three components: work RVU (physician time and effort), practice expense RVU (overhead), and malpractice RVU (professional liability).

Compensation almost always ties to work RVU (wRVU), not total RVU. That distinction matters because the wRVU component is smaller than the total, and it is the physician’s own effort the practice is paying for. If a contract quotes a “conversion factor per RVU” without specifying wRVU, ask which one. The dollar-per-RVU numbers look very different depending on which base you use.

How a Practice Converts wRVU to Physician Pay

The conversion factor is the dollar amount paid per wRVU produced. It varies significantly by specialty, geography, employer type, and negotiating leverage. Primary care conversion factors are lower than surgical specialty conversion factors, and academic centers usually pay differently than hospital-employed models, which usually pay differently than physician-owned groups.

The math is simple. A cardiologist producing 9,000 wRVUs a year at a $65 per wRVU conversion factor earns $585,000 in production comp. That same physician at $55 earns $495,000. The difference is not clinical performance; it is what the contract says. Confirming the current conversion factor for the specialty, market, and employer type is the single highest-leverage step before negotiating.

Base + RVU vs Pure RVU: When Each Works

Compensation structures fall on a spectrum from pure salary to pure RVU. Most contracts sit somewhere in between: a guaranteed base plus a per-RVU rate above a production threshold, sometimes with a stop-loss floor.

Base plus RVU works for physicians in ramping situations, new grads, or specialties where volume is not entirely in the physician’s control. The base cushions slow months. A pure RVU structure works when a physician is established, has stable referral flow, and wants full upside on effort. For a rural Idaho practice where referral patterns take years to build, a pure RVU offer to a new hire is often not a fair structure regardless of the conversion factor.

The Downside Scenarios a Physician Should Model First

Every physician looking at an RVU comp offer should model at least three scenarios before signing:

  • A 15% drop in wRVU production (illness, family leave, market slowdown, a payer network change)
  • An unfavorable schedule change (fewer OR days, added call coverage, reduced clinic capacity)
  • A conversion factor reset (some contracts allow the employer to adjust the factor annually)

The best-case scenario always looks good. The average-case and worst-case scenarios are where contracts get accepted or renegotiated. If the worst-case take-home is materially below what a straight salary would pay, the physician is bearing risk without adequate compensation for it.

What to Ask Before Signing an RVU Contract

Six questions matter more than the headline number:

  • Is the conversion factor tied to work RVU only, or total RVU?
  • Is the conversion factor fixed, or does the employer reset it annually?
  • Is there a production threshold before RVU kicks in, and if so, is the threshold reasonable for the specialty?
  • How are non-billable services (call, admin, teaching) credited?
  • Is there a stop-loss or minimum guarantee?
  • What happens to accrued but unpaid RVU credits if the physician leaves mid-year?

Contracts that answer all six clearly are usually fair. Contracts that leave two or three ambiguous almost always resolve in the employer’s favor at the moment of dispute.

RVU-based pay is not inherently good or bad; it is a structure that rewards specific patterns of work. For a physician-owner running a group, it can align partner comp with production without penalizing the newer physician still building volume. For a physician considering an employed position, the details determine whether the model pays fairly or transfers risk without transferring reward.

Cooper Norman’s healthcare accounting team models RVU comp offers for physicians across Idaho and Utah and reviews partner-comp structures in physician-owned groups. Before signing a new contract or restructuring one, talk with a Cooper Norman advisor about running the scenarios on paper first.

Section 1202 QSBS Exclusion for Manufacturing Owners

An Idaho fabricator sells the business after 20 years and walks away with $12 million of gain on the transaction. Under the general capital gains rules, that gain triggers roughly $2.4 million in federal tax at the 20 percent long-term rate, before state tax and Net Investment Income Tax. Under Section 1202, the same seller could pay zero federal capital gains tax on much of that gain if the company was structured as a C corporation and the owner held the stock for at least five years.

Section 1202 is one of the most valuable planning tools in the code for a growing manufacturer, and it is one of the most commonly missed. Owners routinely form as LLCs or S corporations because those structures work well while the company is operating, then discover at sale time that they left a seven or eight figure exclusion on the table.

What §1202 Excludes and Why It Matters at Sale

Section 1202 excludes from federal income tax the gain on the sale of Qualified Small Business Stock (QSBS) held for more than five years. For stock acquired before September 27, 2010, the exclusion is 50 percent. For stock acquired between September 28, 2010 and July 4, 2025, the exclusion is 100 percent. The One Big Beautiful Bill Act created a tiered exclusion for stock acquired after July 4, 2025: 50 percent at three years of holding, 75 percent at four years, and 100 percent at five years.

The cap is the greater of $15 million per issuer (raised from $10 million by OBBBA, for stock acquired after July 4, 2025) or 10 times the taxpayer’s aggregate adjusted basis in the QSBS. The cap applies per shareholder, per issuer.

The Qualified Small Business Test

To issue QSBS, a company must be a domestic C corporation and must have aggregate gross assets of no more than $75 million at all times before and immediately after the stock is issued (raised from $50 million by OBBBA, for stock acquired after July 4, 2025). The gross assets test uses cash and the adjusted basis of other property. Post-issuance growth beyond the ceiling is allowed. Companies that exceeded the ceiling before issuance are permanently disqualified from issuing QSBS.

Which Manufacturing Activities Qualify

Section 1202 requires an active business use test: the corporation must use at least 80 percent of its assets in a qualified trade or business. Manufacturing squarely qualifies. So do most industrial and technical businesses.

Excluded activities include most services provided by health, law, engineering, architecture, accounting, actuarial, and consulting firms, plus banking, insurance, financing, farming, natural resource extraction, and hospitality. For a pure Idaho or Utah manufacturer, this is not a hard test. For a hybrid business that mixes production with a significant service or resale component, the 80 percent line becomes worth documenting.

The 5-Year Holding Period Requirement

The holding period starts on the date the stock was originally issued to the taxpayer. Stock acquired through a §351 tax-free contribution takes a tacked basis and holding period from the contributed property. Stock received in a §1045 rollover from prior QSBS gets its own tacked holding period.

Sales before five years do not get the full exclusion, but §1045 allows a rollover of gain into replacement QSBS if reinvested within 60 days. For a manufacturer approaching a sale before the five-year mark is hit, a §1045 rollover into new QSBS can preserve the exclusion track for a subsequent sale.

Original Issuance and C-Corporation Requirements

QSBS must be acquired at original issuance in exchange for cash, other property (not stock), or services. Secondary market purchases from other shareholders do not qualify. The company must be a C corporation at the time the stock is issued and generally must remain a C corporation for substantially all of the five-year holding period.

Planning Moves for LLCs and S-Corps

Most family manufacturers are formed as LLCs or S corporations for operational flexibility and single-level tax on operating income. A conversion to C corporation before a planned sale can start the QSBS clock, but it locks in double taxation on operating income during the holding period and forfeits the built-in S corporation earnings from QSBS eligibility.

The decision is a real trade-off: C corporation double tax on operating profits for five years, in exchange for the exclusion on up to $15 million (or 10x basis) of gain at sale. For a business with a defined sale window, real growth ahead, and moderate operating profit relative to eventual sale value, the math often favors the conversion.

QSBS is one of the highest-leverage tax planning tools available to a growing Idaho or Utah manufacturer, and it has to be structured in advance. The manufacturing team at Cooper Norman has run the model for family-owned producers considering C corp conversion, §1045 rollovers, and gift planning that stacks §1202 caps across family members. If you are within a five to seven year window of a possible sale, our valuation and transition planning group is the right first call.

This overview is general information, not tax advice for your specific business. Talk with a Cooper Norman advisor about how these rules apply to your operation.

Section 174 Rd Amortization Manufacturers

For four years, manufacturers watched a punitive change to Section 174 grind through their cash flow. Instead of deducting research and experimental costs in the year they were incurred, plants had to capitalize and amortize those costs over five years for domestic work and fifteen for foreign work. For an Idaho food processor running new-formulation trials or a Utah medical-device manufacturer iterating on tooling, the effect was a tax bill on income that had already been spent.

That regime has now been reversed for domestic work. The One Big Beautiful Bill Act (OBBBA), signed in July 2025, added new Section 174A and restored immediate expensing for domestic research and experimental expenditures for tax years beginning after December 31, 2024. The relief is permanent, with no scheduled sunset.

Here is what that means at the plant level, and what to do before year-end filing.

What the OBBBA change actually does

New Section 174A lets manufacturers deduct qualifying domestic research and experimental costs in the year incurred, the same way most operating expenses are treated. There is no more five-year wait for domestic R&D deductions.

Taxpayers who want to smooth income across years can still elect to capitalize domestic costs and amortize them over a period of not less than sixty months, starting in the month the research benefit is first realized. That election is a planning tool, not a punishment.

Foreign R&D was left in the old regime. Costs tied to research performed outside the United States still amortize over fifteen years under Section 174. For most Cooper Norman clients, that split is manageable, but any manufacturer with an offshore engineering group or contract-development spend abroad should segregate those costs cleanly.

Activities that count as Section 174 work

Section 174 covers the broader universe of research and experimental expenditures, which is wider than the qualified research the Section 41 credit rewards. Expenses that typically fall under 174 include:

  • Wages and benefits for employees performing or directly supporting research
  • Supplies consumed in the research process
  • Contract research paid to outside firms
  • Software development, including internal-use software
  • Overhead reasonably allocated to research activity

Software development remains inside Section 174 by statute, which matters for manufacturers running their own MES, quality, or IoT platforms.

The 2022 through 2024 problem, and what to do about it

The retroactive relief window for small businesses closed on July 6, 2026. Businesses with average annual gross receipts of $31 million or less were allowed to amend 2022, 2023, and 2024 returns to apply immediate domestic expensing. If you were eligible and did not amend, that window is now shut.

Larger manufacturers, and any business that did not amend during the window, will still be carrying unamortized Section 174 balances from prior years. Those balances continue to amortize on the original schedule until fully deducted. Cooper Norman advisors can model out the remaining amortization runway and flag any accounting-method-change filings still available.

Planning moves worth running before year-end

Several decisions can move real dollars for a plant this year:

  • Segregate domestic and foreign R&D at the source. Chart-of-accounts changes made in Q4 are far cleaner than trying to split time cards in March.
  • Coordinate Section 174A with the Section 41 R&D credit. They are different provisions, and the credit is still available for qualified research on top of immediate expensing.
  • Look at software development spend deliberately. Custom software, PLC programming, and MES work often qualify under both 174 and 41 when documented as they occur.
  • Model cash flow with the change baked in. Many manufacturers built quarterly estimates around amortized 174. Reforecast now so estimated payments do not overshoot.

What still requires attention

Section 174A is not a blank check. Contemporaneous documentation still matters, and the line between operating expense and Section 174 expenditure is not always obvious. Prototype builds, tooling development, and formulation trials read differently to a plant manager than they do to a revenue agent, and the difference shows up on audit.

For Idaho and Utah manufacturers with growing R&D spend, particularly in food processing, aerospace components, and medical devices, running a mid-year check with your CPA on how Section 174A is being applied is time well spent.

This overview is general information, not tax advice for your specific business. Talk with a Cooper Norman advisor about how these rules apply to your operation, and how they interact with the tax planning you already have in place.

Section 179 vs. Bonus Depreciation for Farm Equipment: Which One Wins on Your Next Purchase?

For Idaho and Utah farmers weighing a fall equipment purchase, the question is not whether to write it off. It is how. The tax code offers two paths, Section 179 expensing and bonus depreciation, and picking the wrong one leaves real money on the table at filing.

Both rules let you accelerate deductions on qualifying farm assets. They work differently, they interact differently with state tax, and they favor different situations. A potato grower buying a $200,000 sprayer in October has a different answer than a Cassia County dairy investing in a $1.2 million parlor upgrade.

Here is how to decide before the purchase order is signed.

The two write-offs, side by side

Section 179 lets a farmer elect to expense qualifying property, treating the purchase as an ordinary business deduction in the year the equipment is placed in service. There is an annual dollar cap and a phase-out that reduces the deduction when total qualifying purchases exceed a threshold. Section 179 cannot create or increase a net operating loss, so it is limited to your active farm income.

Bonus depreciation allows a percentage of the cost of qualifying property to be deducted in year one, on top of or instead of Section 179. It has no dollar cap and no income limit, so it can create or extend a loss. Under the One Big Beautiful Bill Act signed in 2025, bonus depreciation was restored to 100% for qualifying property placed in service after Jan. 19, 2025.

Section 179 is asset-by-asset. Bonus depreciation is generally all-or-nothing by class life. That matters if you want to expense some purchases and depreciate others normally.

When Section 179 is the better move

Section 179 shines on small and mid-size purchases when the farm has active taxable income to absorb the deduction. It is also better when you want to pick and choose. You can Section 179 one piece of equipment, take regular depreciation on another, and match the deductions to the tax year you actually want them.

For a hay operation buying a used baler and a set of rakes, Section 179 lets you accelerate the baler and leave the rakes on a standard MACRS schedule. That kind of asset-by-asset control is not available under bonus.

When bonus depreciation wins

Bonus depreciation is the better tool for very large purchases, for farms with rental or passive income streams that Section 179 cannot touch, and for years when you need to create or extend a farm loss.

A Bingham County potato grower who buys $1.5 million of new field equipment in one year can move faster with bonus depreciation than by chaining Section 179 elections across future years. The same is true for a Rexburg dairy expanding facilities that include qualifying single-purpose agricultural structures, drainage tile, and other 15-year land improvements.

Farm buildings on shorter lives, single-purpose agricultural structures, and drainage tile can qualify for bonus depreciation. That is a real advantage over Section 179 when the depreciable life is 20 years or less.

Idaho and Utah state conformity

Federal is only half the picture. Idaho generally conforms to the Internal Revenue Code, which means most federal depreciation choices flow through to the state return, but conformity dates and specific adjustments should be checked with the Idaho State Tax Commission for the current tax year. Utah has historically decoupled from bonus depreciation in some years, so a Cache Valley or Sanpete operation may see a different state result than a neighbor across the Idaho line.

If you own equipment or land in both states, or if your operation crosses the line at any point in the year, run the state math separately. The federal answer does not decide the state answer.

A fall decision framework

Before you sign for equipment this fall, walk through these five steps.

1. Forecast your farm net income for the year, honestly. Section 179 cannot exceed it. 2. Total your expected qualifying property purchases. If you are close to the Section 179 phase-out threshold, the math changes fast. 3. Tag each asset by expected use. A center pivot, a combine, and a shop building have different class lives and different treatment under bonus. 4. Model both methods with a rough tax-year projection. Sometimes a mix wins, Section 179 for one asset, bonus for another. 5. Document the placed-in-service date. Equipment sitting on a trailer at year-end does not qualify. Equipment plugged in and ready to run does.

Run the numbers before the sale closes, not after. The write-off does not fix a bad purchase, but the right election on a good one can move real tax dollars.

This overview is general information, not tax advice for your specific operation. Talk with a Cooper Norman agriculture accounting team about how these rules apply to your farm, and how the current year’s tax planning services fit your equipment plans. When the numbers matter, reach out to a Cooper Norman advisor before you place the order.

Section 179 vs. Bonus Depreciation: A Medical Practice Guide

A physician buying $150,000 of new imaging or a dental office replacing four operatory chairs can write off far more in year one than most owners realize. The mechanics come down to two elections: Section 179 and bonus depreciation. Choose the right one and you can front-load six figures of deduction into the year the equipment is placed in service. Choose the wrong one, or fail to plan the timing, and you leave real money on the table.

Both provisions apply to Section 179 medical equipment purchases, but they work differently, have different limits, and interact with state tax rules in ways Idaho and Utah practice owners should not assume are identical to federal. Here is how the two elections stack up in 2026 and how to decide which one fits a given purchase.

What Section 179 Covers for Medical and Dental Practices

Section 179 lets a practice immediately expense the full cost of qualifying tangible property in the year it is placed in service, up to an annual limit. For tax year 2026 the maximum deduction is $2,560,000, and the deduction begins to phase out dollar for dollar once total qualifying purchases exceed $4,090,000. Very few private medical or dental practices hit that ceiling in a single year, which means the practical cap is the business income limitation: Section 179 cannot create or increase a taxable loss.

Qualifying property includes new and used equipment such as imaging units, chairs, sterilizers, digital scanners, ultrasound, lasers, office furniture, computer hardware, and off-the-shelf software. Section 179 also covers certain improvements to nonresidential real property, including HVAC, roofs, security systems, and fire protection, once the building is already in service.

How Bonus Depreciation Works After the OBBBA

Bonus depreciation is a first-year deduction taken on qualified property in addition to any Section 179 election. Under the One Big Beautiful Bill Act signed in July 2025, Congress restored 100 percent bonus depreciation permanently for qualifying property placed in service on or after January 19, 2025. The scheduled 60-40-20 percent phase-down that applied under the TCJA is gone.

Qualified property still generally means tangible property with a recovery period of 20 years or less, along with certain qualified improvement property. Both new and used equipment qualify, provided the practice did not previously use it.

Because bonus depreciation is not limited by the Section 179 annual cap, and because it can create or increase a net operating loss, it becomes the workhorse for larger single-year purchases or for practices with modest current-year income.

Section 179 vs. Bonus Depreciation: Which Election Wins When

The decision comes down to three factors: total qualifying purchases, current-year taxable income, and how each state treats the deduction.

Use Section 179 when you want line-item control. A practice can pick which specific assets to expense and elect only part of the cost, spreading the rest over regular depreciation. That flexibility matters when a practice owner is managing income around the QBI phase-in range, an S-corp shareholder wage base, or a partnership special allocation.

Use bonus depreciation when the purchase is large enough to bump against the Section 179 business-income limit, when the practice expects to run a net operating loss, or when a physician-owner is planning to acquire equipment through a partnership and needs a partner-level deduction that flows regardless of practice-level income.

Practices often use both. A $500,000 equipment year might see $250,000 elected under Section 179 to manage the shareholder wage base, with the balance taken as 100 percent bonus depreciation on the remaining assets.

Idaho and Utah State Conformity

Federal is only half the picture. Idaho conforms to the Internal Revenue Code as of a fixed date and revisits that conformity each legislative session. Utah tracks the federal treatment of Section 179 and bonus depreciation reasonably closely but has historically decoupled in specific years. A deduction that saves a physician forty percent federally may recover only part of that on the state return depending on which conformity update is in force.

Before you sign a purchase order, confirm the current state conformity status for the year the property will be placed in service. The state math often changes the ranking between the two elections.

Common Mistakes When Writing Off Medical Equipment

Three mistakes come up more than any other. First, placing property “in service” is the trigger, not signing the invoice or taking delivery. A CBCT unit sitting in a crate until January produces no year-one deduction for the prior year. Second, listed property such as vehicles used for practice errands carries stricter substantiation rules and lower luxury caps. Third, Section 179 recapture applies if business use drops below 50 percent, which occasionally catches owners who lease equipment out to another entity.

The right answer for a specific purchase depends on the practice’s entity type, the shareholder-wage strategy, projected taxable income, and whether Idaho or Utah is the state return. Run the numbers with a CPA before you sign. Our team at Cooper Norman advises medical and dental practice owners across Idaho and Utah on practice tax planning, and equipment timing is one of the highest-leverage conversations we have.

This overview is general information, not tax advice for your specific situation.

Section 45X Advanced Manufacturing Credit

Cooper Norman sees more manufacturers asking about Section 45X every quarter, and most are surprised to learn that the credit is a direct cash lever rather than a deduction against income. Section 45X, added by the Inflation Reduction Act and refined by IRS guidance, pays U.S. producers a per-unit credit for eligible components sold to unrelated parties.

The credit is denominated in dollars per unit and stacks with other production incentives. For a Utah battery-component or solar-adjacent manufacturer, or an Idaho processor of qualifying critical minerals, that per-unit math can dwarf a comparable R&D credit. Here is what qualifies, how the credit is claimed, and how the phaseout schedule affects the timeline.

What Section 45X rewards

Section 45X pays a credit for eligible components produced by the taxpayer in the United States and sold to an unrelated person. The four families of eligible components are:

  • Solar energy components (photovoltaic cells, wafers, modules, polymeric backsheets, torque tubes, structural fasteners)
  • Wind energy components (blades, nacelles, towers, offshore wind foundations)
  • Inverters, including central, utility, commercial, residential, and microinverters
  • Electrode active materials, battery cells, and battery modules
  • Applicable critical minerals

Each component has its own per-unit credit amount defined in the statute or by Treasury regulation. Battery cells, for example, are credited by kilowatt-hour of capacity, while solar modules are credited by watt of direct-current capacity.

Who claims the credit

The credit belongs to the producer. Two rules matter for that determination:

  • The producer must manufacture the component in the United States or a U.S. territory.
  • The component must be sold to a person unrelated to the producer. Related-party sales generally do not generate a credit unless a related-party election is made.

Contract manufacturing arrangements have their own rules under the Treasury regulations. Which party is treated as producing the component depends on who bears the economic risk and who directs the manufacturing activities, not just whose name is on the shipping paperwork.

Direct pay and credit transferability

Section 45X credits can be monetized in two ways beyond the traditional offset against tax liability:

  • Direct pay. Tax-exempt entities, states, and certain other applicable entities can elect to receive the credit as a refundable payment.
  • Transferability. Taxable manufacturers can sell all or part of a credit to an unrelated party for cash. The buyer applies the credit against its own tax liability.

Transferability changed the economics of the credit meaningfully. A profitable manufacturer with no immediate use for the credit can convert it to cash by finding a transferee, typically at a small discount to face value. Cooper Norman helps clients evaluate whether transfer or carryforward is the right move given projected tax liability.

Phaseout schedule and what it means for planning

Full-value credits are available through 2029 for most eligible components. The phaseout schedule then reduces the credit as follows:

  • 75% of full credit for components sold in calendar year 2030
  • 50% of full credit for components sold in calendar year 2031
  • 25% of full credit for components sold in calendar year 2032
  • Credit expires for components sold after December 31, 2032

Two exceptions matter. Wind components are no longer eligible for §45X credits generated after 2027. Critical minerals, originally exempt from the phaseout, are now subject to a staged phaseout from 2031 through 2034 under legislation enacted after the original IRA.

The practical read is that any capacity coming online in 2026 or 2027 captures the full credit for its earliest, highest-volume production years. Delays into 2030 leave real dollars on the table.

Documentation standards to prepare now

The IRS will require, at minimum, records that establish:

  • The component produced, quantity, and technical specification
  • The place of production, tied to the U.S.-manufactured requirement
  • The identity of the purchaser and their unrelated-party status
  • Bills of materials and process documentation supporting the component’s classification

Manufacturers pursuing transferability face additional documentation, including a required registration process with the IRS before a transfer election can be made.

For Idaho and Utah manufacturers building capacity in battery components, solar-adjacent parts, or applicable critical minerals, the credit is worth an intentional pass through the numbers before capital planning is finalized.

This overview is general information, not tax advice for your specific business. Talk with a Cooper Norman advisor about how Section 45X fits with your production timeline and tax planning.

Selling Your Practice to a DSO, MSO, or PPM: What to Expect

Unsolicited offers to buy medical and dental practices are common again, and most of them come from three types of buyers that get abbreviated with three letters. DSO. MSO. PPM. Each one behaves differently, structures deals differently, and produces a different life after close. An owner-doctor in Idaho or Utah who receives one of these letters in the mail deserves to know which type of buyer is on the other end of the conversation before signing an LOI.

The mistake most owners make is treating the three as interchangeable. They are not. This piece walks through the structural differences, how deal consideration usually gets split between cash, rollover equity, and post-close comp, the EBITDA adjustments buyers push during diligence, the tax treatment that actually changes take-home, and what life looks like after the ink dries.

DSO vs. MSO vs. PPM: The Structural Differences

A dental support organization (DSO) is the dental industry’s version of a management services company. In most states, a DSO cannot own the clinical entity outright due to corporate-practice-of-dentistry rules, so it typically buys the practice’s non-clinical assets and enters a management services agreement with the dentist-owned professional entity.

A management services organization (MSO) is the medical equivalent, structured similarly around corporate-practice-of-medicine restrictions. The MSO owns the non-clinical business; the physicians retain the clinical entity and contract with the MSO for management services.

A physician practice management company (PPM) is a broader term for larger, often publicly traded, physician management platforms. Some PPMs are private-equity-backed roll-ups; others are hospital-affiliated. The economics vary.

The abbreviation matters because it shapes what the buyer can and cannot own, how the deal must be structured, and how much post-close autonomy the physician retains over clinical decisions.

How Deal Consideration Is Split (Cash, Rollover, Earnout, Comp)

The headline price is rarely what the seller receives at closing. A typical DSO or MSO deal splits consideration four ways:

  • Cash at closing, usually 60 to 80% of the total enterprise value
  • Rollover equity in the acquiring platform, held until a future “second bite” liquidity event
  • Earnouts tied to post-close performance targets
  • Ongoing physician compensation, negotiated as part of the employment agreement

Cash at closing is real money. Rollover equity is a lottery ticket that pays if the platform sells again at a higher multiple, and pays nothing if the platform stalls. Earnouts pay if targets are hit and lose disputes at the moment of measurement. Post-close comp is often the largest single line item over the life of the deal, and it is the number the seller controls least.

EBITDA Adjustments the Buyer Will Push

Buyers do not pay a multiple on the practice’s reported earnings. They pay a multiple on adjusted EBITDA, and the adjustment negotiation is where deal value moves. Common adjustments buyers push during diligence:

  • Reducing owner-doctor comp to a market-rate replacement salary (this raises EBITDA and price)
  • Backing out one-time expenses (legitimate) and recurring expenses claimed as one-time (contested)
  • Normalizing rent to fair market value if the practice pays above-market to a related landlord
  • Adding back personal-use expenses run through the practice

The direction of these adjustments is usually favorable to the seller in the aggregate. The seller who does not have a CPA running the adjustment math independently is negotiating without a floor.

The Tax Treatment That Actually Changes Your Take-Home

Federal tax treatment can move the seller’s after-tax take-home by 10 to 20 percentage points depending on how the deal is structured. Three common structures:

An asset sale generally produces ordinary income on depreciation recapture and capital gain on goodwill. It is common in DSO deals because the buyer wants a stepped-up basis and the practice entity is a professional entity that cannot be acquired directly.

A stock or membership interest sale generally produces capital gain to the seller and gives the buyer carryover basis. Simpler tax treatment for the seller; less attractive to the buyer.

An F-reorganization is a specific structure that lets an S corporation seller achieve a mostly capital-gain outcome while still delivering a buyer-friendly asset-purchase structure. It is common in higher-value practice deals and worth understanding in advance.

Life After Close: Autonomy, Culture, and Comp

The physician who sells to a DSO or MSO does not usually stop working the next day. Most deals require a post-close employment or services agreement of three to five years. What that life looks like depends heavily on the acquirer’s operating model.

Two questions worth asking every acquirer during diligence:

  • What decisions do the physicians in your existing acquired practices make, and what decisions have moved to corporate?
  • How does the compensation model change post-close, and what is the actual take-home difference for the physicians in year three?

Cooper Norman’s healthcare valuation team and transition planning team represent physician-owners across Idaho and Utah in DSO, MSO, and PPM sale conversations, running the EBITDA and tax math before an LOI is signed. To review an offer, talk with a Cooper Norman advisor.

SKU-Level Profitability: How Retailers Find Hidden Losers

A retailer with 800 SKUs and a healthy blended gross margin often has 100 SKUs quietly losing money and does not know it. Blended margins average the winners with the losers, and unless someone has done the allocation work, the losers stay on the shelf, absorb inventory dollars, and drag on cash flow. For an Idaho outdoor retailer, a Utah e-commerce brand, or a specialty grocer working with distributor lines, SKU-level profitability is one of the highest-leverage analyses on the finance side of the business.

The math is not complicated. The discipline is.

Why Blended Margins Hide Money-Losing SKUs

A gross margin figure at the category or department level obscures three things. It hides SKUs where actual landed cost has drifted higher than the last review. It masks SKUs that carry disproportionate handling, freight, or shrinkage cost. And it fails to reflect the true cost of holding an item in inventory for six or twelve months when a comparable item turns four times as fast.

The result is a portfolio in which a handful of hero SKUs subsidize a long tail of items that would fail a proper margin test if they were evaluated on their own.

The Four-Step Allocation That Reveals True SKU Cost

Real SKU profitability requires pulling apart the cost line into pieces that can be allocated per unit. A working four-step model:

  1. Landed cost per unit: supplier cost, inbound freight, duty, currency conversion, tariff. Update at least twice a year, or every time a supplier price change lands.
  2. Direct handling cost: receiving, put-away, pick, pack, and outbound freight per unit. Small items in high volume can carry disproportionate handling cost as a share of price.
  3. Inventory carrying cost: capital cost of inventory times average days on hand, plus warehouse space, insurance, and obsolescence reserve. Slow SKUs get penalized here.
  4. Category overhead allocation: merchandising, marketing, and store or platform operating costs allocated by revenue share or slot count.

Contribution margin per unit equals selling price minus the first three items. Fully allocated profit adds the fourth. Both figures matter, but contribution margin is the more actionable number for pruning decisions.

The 80/20 Trap: Long-Tail SKUs and Carrying Cost

Pareto’s rule almost always shows up in a SKU analysis: 20 percent of SKUs generate 80 percent of revenue. The other 80 percent of SKUs are the long tail. In some retailers, the long tail is a real strategic asset because it broadens the assortment and drives basket size. In others, it is a slow-moving inventory anchor absorbing carrying cost with no reciprocal revenue lift.

The tell is turnover. Fast-turning long-tail SKUs earn their space. Slow-turning long-tail SKUs, especially those with a full year of dust on the shelf, rarely do.

How Often to Rerun the Analysis

Twice a year is usually enough for most retailers, with a lightweight monthly check on the fastest-changing categories. Cost changes on inbound goods, tariff shifts, and shipping cost volatility can all move a SKU from margin-positive to margin-negative in a single quarter. Set a threshold (for example, any SKU whose contribution margin falls below a set floor for two consecutive months) and flag those for pricing action or delisting.

What to Do With Losing SKUs Before Killing Them

Four options before a delist decision:

  • Raise price. Test elasticity on categories where the SKU is not a signpost item.
  • Negotiate cost. Volume commitments, container-load orders, or an alternate supplier can pull landed cost down 5 to 15 percent.
  • Reduce handling cost. Case-pack ordering, pre-labeling from the supplier, or slotting near pick paths can pull handling per unit down.
  • Shrink the buy. Some SKUs are worth keeping on the shelf at a lower stocking level; they just do not deserve the depth they currently have.

Delist is the last option, not the first, because delist can shrink assortment perception and drive cross-selling losses.

Communicating SKU Cuts to Buyers and Vendors

Buyers frequently disagree with delist recommendations because they weight assortment and vendor relationships alongside pure margin math. That disagreement is healthy. The right process brings buyer, finance, and category management together with the same SKU-level profit report and negotiates the cuts in the open.

Vendors respond better to a data-driven conversation than a surprise letter. Sharing the SKU-level margin numbers before the cut is announced often surfaces cost concessions or promotional support that saves the SKU.

Cleaning up a SKU portfolio is one of the fastest ways to free working capital in a retail business. The retail advisory team at Cooper Norman has run this analysis for Idaho and Utah retailers across grocery, specialty, and e-commerce. If your blended margin looks fine but cash is tight, our fractional CFO group can help you find where it went.